Radiographic Position of the Electrode as a Predictor of the Outcome of InterStim Therapy.
- Author:
Abdullah Ahmed GAHZI
1
;
Mai Ahmed BANAKHAR
;
Dean S ELTERMAN
;
Magdy HASSOUNA
Author Information
- Publication Type:Original Article
- Keywords: Sacral Neuromodulation; Urinary Bladder, Overactive; Urinary Incontinence; Urinary Retention
- MeSH: Electrodes*; Female; Follow-Up Studies; Humans; Lower Urinary Tract Symptoms; Male; Pelvic Pain; Retrospective Studies; Sacrum; Salvage Therapy; Surgeons; Urinary Bladder, Overactive; Urinary Incontinence; Urinary Retention
- From:International Neurourology Journal 2017;21(4):289-294
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: Sacral neuromodulation (SNM) therapy is indicated for some refractory urological conditions. The electrode lead position in sacral x-rays during routine follow-up may predict the outcome of SNM therapy. To determine whether the radiographic position of the electrode in the sacral foramen predicted the long-term outcome of SNM therapy. METHODS: This was a retrospective study of patients who underwent InterStim SNM at Toronto Western Hospital by 2 surgeons from July 2013 to March 2014. The position of electrodes in relation to the sacral bone was assessed on follow-up sacral x-rays. In the lateral view, we determined the location of the radio-opaque marker of the electrode relative to the inner surface of the sacrum (P3, D3, P2, D2, P1, D1, P0, and D0). In the anteroposterior view, the angle between a line through the spinous process shadow and the electrode was measured (0°–30°, 30°–60°, 60°–90°, >90°, or medial). Dissatisfied patients were defined as those who did not improve based on a voiding diary or those who needed salvage treatment after SNM. The primary endpoint was to determine whether the electrode lead position on sacral x-rays predicted the outcome of SNM therapy. RESULTS: A total of 69 patients (61 female and 8 male patients) were included, with a median age of 55 years. Forty-two of the patients (60.9%) had refractory overactive bladder, 21 (30.4%) suffered from chronic urinary retention, and 6 (8.7%) had lower urinary tract symptoms and chronic pelvic pain syndrome. The univariate analysis did not show any correlation between SNM response and the electrode position or angle. Dummy regression analysis using response to implantation as the dependent outcome variable did not show any significance for any of the predictors. CONCLUSIONS: Our study did not show a correlation between the long-term response to SNM and the electrode position on follow-up sacral x-rays. In this study, electrode lead position in sacral x-ray at follow-up was not correlated with the outcome of SNM therapy.
